ARC-1000 Fundus Camera

The ARC-1000 is a non-mydriatic automated portable fundus camera developed by Acer Medical to complement its VeriSee AI screening software suite. The device captures high-resolution retinal images without pupil dilation, enabling efficient diabetic retinopathy and macular degeneration screening in primary care settings.

Product Overview

Acer Medical designed the ARC-1000 as the hardware component of an integrated AI-assisted ophthalmology screening solution. Combined with VeriSee DR and VeriSee AMD software running on Acer AI PCs, the system provides a complete workflow from image capture to AI-powered diagnostic recommendations.

The non-mydriatic capability eliminates the need for pupil-dilating eye drops, significantly reducing patient discomfort and examination time. This feature proves particularly valuable in diabetes clinics and health screening centers where patients may not expect ophthalmologic procedures and prefer minimal intervention.

Key Features

For diabetes clinics and primary care screening programs, Acer Medical’s ARC-1000 captures non-mydriatic retinal images in portable form, natively compatible with VeriSee AI screening software on Acer AI PCs.

• Non-Mydriatic Operation: Captures fundus images without pupil dilation
• Automated Capture: Simplifies image acquisition for efficient patient throughput
• Portable Design: Enables deployment across multiple clinical locations
• VeriSee Integration: Native compatibility with Acer Medical AI screening software
• AI PC Connectivity: Direct connection to Acer AI PC for immediate image analysis

Technical Specifications

For AI-assisted eye screening, the ARC-1000 pairs directly with Acer AI PCs running VeriSee DR and VeriSee AMD software, approved by Taiwan TFDA in 2022 and Malaysia and Indonesia regulators by 2024.

Clinical Applications

The ARC-1000 serves healthcare facilities implementing AI-assisted eye screening programs. Primary use cases include:

• Diabetes clinics requiring routine diabetic retinopathy surveillance
• Health examination centers offering full eye assessments
• Primary care facilities conducting opportunistic screening
• Mobile health programs serving remote communities

When paired with VeriSee software on Acer AI PCs powered by Intel Core Ultra processors, the system processes captured images in real-time without network connectivity, maintaining patient data privacy while enabling immediate screening results.

Regulatory Status

System Integration

The ARC-1000 forms part of Acer Medical’s AI screening solution alongside:

• VeriSee DR: AI software for diabetic retinopathy detection
• VeriSee AMD: AI software for macular degeneration screening
• Acer AI PC: Intel Core Ultra-powered processing platform

This integrated approach provides healthcare institutions with a turnkey solution requiring minimal technical integration effort.

Frequently Asked Questions

What does non-mydriatic mean for patients?

Non-mydriatic imaging means the fundus camera can capture retinal photographs without administering pupil-dilating drops. Patients experience less discomfort, no temporary vision blurring, and can resume normal activities immediately after examination.

Is the ARC-1000 sold separately from VeriSee software?

Acer Medical offers the ARC-1000 as part of integrated screening solutions that include VeriSee software and Acer AI PC hardware. Contact Acer Medical directly for specific configuration options.

Which clinical settings are best suited for ARC-1000 deployment?

The ARC-1000 is designed for diabetes clinics, health examination centers, primary care facilities, and mobile screening programs where non-mydriatic portable fundus imaging enables efficient patient workflows.